Lumiio Secures Spot in Plug and Play Alberta’s First Digital Health Accelerator Program Cohort
Lumiio has been selected to join Plug and Play Alberta’s prestigious digital health accelerator program, the first of its kind at the newly built Alberta offices.
Through this 12-week program, Lumiio will have the opportunity to connect with global pharmaceutical companies such as Roche, Boehringer Ingelheim, and Pfizer, as well as other important ecosystem players to help expand the reach of our digital health programs. The company will also get the opportunity to connect with an array of resources including mentorship programs, meetings with global VC’s and other potential investors, and other hands-on expertise to help grow our reach.
The opportunity came out of Plug and Play Alberta’s first Selection Day event, where the Lumiio team pitched alongside 24 other startups to the investors and corporations that will be working with us throughout the program. This event launched shortly after the opening of Plug and Play’s headquarters in Calgary.
“This opportunity to connect with leaders in digital health through this globally recognized program is hugely exciting for us,” said Lumiio CEO Blaine Penny. “This will be an important step for us in reaching our goal of empowering 1000 health communities around the world by 2030.”
Headquartered in Silicon Valley with 40 locations around the world, Plug and Play is one of largest global accelerators, and one of the most active Startup investors globally. The global tech investor has a network of over 30,000 startups, more than 500 corporations, and hundreds of venture capital firms, government agencies and university research programs. The program will begin mid-March and conclude with a second pitch event where companies will showcase the progress they’ve made throughout the course of the program.